144 research outputs found

    CA21115 - Iron-sulphur (FeS) clusters: from chemistry to immunology (FeSImmChemNet)

    Get PDF
    FeS clusters are the oldest biological cofactors. They play a role in various cellular processes, in all steps of the innate immune response to pathogens and the replication process of many viruses like SARS-CoV-2. Consequently, understanding the chemistry and biology of FeS clusters is essential for understanding the mechanism of cell development, the functioning of the immune response to pathogens, and the viral replication process. To elucidate the roles of FeS clusters and proteins in these processes and use the fundamental knowledge for developing therapeutics, the Action aims to build a coordinated effort applying multidisciplinary approaches combining stem cell biology, immunology and virology, metabolomics, bioinorganic chemistry, and computational and medicinal chemistry. The resulting knowledge will reveal new therapeutic targets or approaches to treating many human diseases, including viral infection, neurodegeneration and cancer. Bridging these fields is not possible without access to a Network, where experts in these fields can share their findings, exchange ideas, and develop new research agendas and projects

    ЀармакотСрапСвтски ΠΈ Ρ‚ΠΎΠΊΡΠΈΠΊΠΎΠ»ΠΎΡˆΠΊΠΈ аспСкти Π½Π° ΠΈΠ·Π±Ρ€Π°Π½ΠΈ Π»Π΅ΠΊΠΎΠ²ΠΈ ΠΊΠΎΠΈ Π΄Π΅Π»ΡƒΠ²Π°Π°Ρ‚ Π½Π° кардиоваскуларниот систСм

    Get PDF
    ΠŸΠΎΠ²Π΅ΡœΠ΅Ρ‚ΠΎ ΠΎΠ΄ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΈΡ‚Π΅ Π·Π΅ΠΌΠ°Π°Ρ‚ повСќС Π»Π΅ΠΊΠΎΠ²ΠΈ Π·Π° Ρ‚Π΅Ρ€Π°ΠΏΠΈΡ˜Π° Π½Π° Π½ΠΈΠ²Π½ΠΈ Ρ€Π°Π·Π»ΠΈΡ‡Π½ΠΈ болСсти. ΠŸΡ€ΠΈΠ±Π»ΠΈΠΆΠ½ΠΎ 70 Π΄ΠΎ 90 ΠΏΡ€ΠΎΡ†Π΅Π½Ρ‚ΠΈ ΠΎΠ΄ повозраснитС Π»ΠΈΡ†Π° Π·Π΅ΠΌΠ°Π°Ρ‚ Π±Π°Ρ€Π΅ΠΌ Π΅Π΄Π΅Π½ ΠΏΠ΅Ρ€ΠΎΡ€Π°Π»Π΅Π½ Π»Π΅ΠΊ Π΄Π½Π΅Π²Π½ΠΎ, Π΄ΠΎΠ΄Π΅ΠΊΠ° Π²ΠΎ просСк Π½Π° ΠΎΠ²ΠΈΠ΅ Π»ΠΈΡ†Π° ΠΈΠΌ сС ΠΏΡ€Π΅ΠΏΠΈΡˆΡƒΠ²Π°Π°Ρ‚ Π΄Π²Π° Π΄ΠΎ ΠΏΠ΅Ρ‚ Ρ€Π°Π·Π»ΠΈΡ‡Π½ΠΈ Π»Π΅ΠΊΠΎΠ²ΠΈ Π²ΠΎ Ρ‚Π΅ΠΊ Π½Π° Π³ΠΎΠ΄ΠΈΠ½Π°Ρ‚Π°. ΠŸΠΎΡ‚Π΅Π½Ρ†ΠΈΡ˜Π°Π»ΠΎΡ‚ Π·Π° ΠΈΠ½Ρ‚Π΅Ρ€Π°ΠΊΡ†ΠΈΠΈ со Π»Π΅ΠΊΠΎΠ²ΠΈ сС Π·Π³ΠΎΠ»Π΅ΠΌΡƒΠ²Π° со Π±Ρ€ΠΎΡ˜ΠΎΡ‚ Π½Π° администрирани Π»Π΅ΠΊΠΎΠ²ΠΈ. ΠŸΡ€ΠΎΡ†Π΅Π½Π΅Ρ‚ΠΈΠΎΡ‚ Ρ€ΠΈΠ·ΠΈΠΊ ΠΎΠ΄ нСсакани Π΅Ρ„Π΅ΠΊΡ‚ΠΈ ΠΎΠ΄ Π»Π΅ΠΊΠΎΡ‚ Π΅ 13% ΠΏΡ€ΠΈ ΠΏΡ€ΠΈΠ΅ΠΌ Π½Π° 2 Π»Π΅ΠΊΠ°, 58% Π·Π° 5 Π»Π΅ΠΊΠΎΠ²ΠΈ ΠΈ Π΄ΡƒΡ€ΠΈ 82% Π·Π° 7 ΠΈΠ»ΠΈ повСќС Π»Π΅ΠΊΠΎΠ²ΠΈ. Π’Π΅Ρ€Π°ΠΏΠΈΡ˜Π°Ρ‚Π° со повСќС Π»Π΅ΠΊΠΎΠ²ΠΈ сСкогаш Π΅ ΠΏΠΎΠ²Ρ€Π·Π°Π½Π° со висок Ρ€ΠΈΠ·ΠΈΠΊ Π½Π° ΠΏΠΎΡ‚Π΅Π½Ρ†ΠΈΡ˜Π°Π»Π½ΠΎ сСриозни ΠΈΠ½Ρ‚Π΅Ρ€Π°ΠΊΡ†ΠΈΠΈ ΠΌΠ΅Ρ“Ρƒ Π»Π΅ΠΊΠΎΠ²ΠΈΡ‚Π΅, ΠΈΠ½Ρ‚Π΅Ρ€Π°ΠΊΡ†ΠΈΠΈ со мСдицински ΠΈΠ½Ρ‚Π΅Ρ€Π²Π΅Π½Ρ†ΠΈΠΈ ΠΈ Π½Π΅Π³Π°Ρ‚ΠΈΠ²Π½ΠΈ нСсакани Π΅Ρ„Π΅ΠΊΡ‚ΠΈ Π½Π° Π»Π΅ΠΊΠΎΠ²ΠΈΡ‚Π΅. Π›Π΅ΠΊ-Π»Π΅ΠΊ ΠΈΠ½Ρ‚Π΅Ρ€Π°ΠΊΡ†ΠΈΠΈΡ‚Π΅ сС Ρ˜Π°Π²ΡƒΠ²Π°Π°Ρ‚ ΠΊΠΎΠ³Π° Π΄Ρ€ΡƒΠ³ Ρ„Π°ΠΊΡ‚ΠΎΡ€ (Π²Ρ‚ΠΎΡ€ΠΈΠΎΡ‚ Π»Π΅ΠΊ) влијаС Π½Π° Ρ„Π°Ρ€ΠΌΠ°ΠΊΠΎΠΊΠΈΠ½Π΅Ρ‚ΠΈΠΊΠ°Ρ‚Π° ΠΈΠ»ΠΈ Ρ„Π°Ρ€ΠΌΠ°ΠΊΠΎΠ΄ΠΈΠ½Π°ΠΌΠΈΠΊΠ°Ρ‚Π° Π½Π° карактСристичниот Π»Π΅ΠΊ (ΠΏΡ€Π²ΠΈΠΎΡ‚ Π»Π΅ΠΊ) ΠΈ Π³ΠΎ Π²Π»ΠΎΡˆΡƒΠ²Π° ΠΏΠΎΠ·Π½Π°Ρ‚ΠΈΠΎΡ‚ нСсакан Π΅Ρ„Π΅ΠΊΡ‚ Π½Π° ΠΏΡ€Π²ΠΈΠΎΡ‚ Π»Π΅ΠΊ, ΡˆΡ‚ΠΎ ΠΌΠΎΠΆΠ΅ Π΄Π° ја Π·Π³ΠΎΠ»Π΅ΠΌΠΈ токсичноста ΠΈΠ»ΠΈ Π΄Π° Π³ΠΎ Π½Π°ΠΌΠ°Π»ΠΈ тСрапСвтскиот Π΅Ρ„Π΅ΠΊΡ‚ Π½Π° истиот. ПовСќС ΠΎΠ΄ ΠΏΠΎΠ»ΠΎΠ²ΠΈΠ½Π°Ρ‚Π° ΠΎΠ΄ нСсаканитС Π΅Ρ„Π΅ΠΊΡ‚ΠΈ Π½Π° Π»Π΅ΠΊΠΎΡ‚ ΠΏΡ€ΠΎΠΈΠ·Π»Π΅Π³ΡƒΠ²Π°Π°Ρ‚ ΠΎΠ΄ ΠΏΡ€ΠΈΠ΅ΠΌΠΎΡ‚ Π½Π° Π»Π΅ΠΊΠΎΠ²ΠΈ ΠΊΠ°ΠΊΠΎ ΡˆΡ‚ΠΎ сС кортикостСроиди, нСстСроидни Π°Π½Ρ‚ΠΈΠΈΠ½Ρ„Π»Π°ΠΌΠ°Ρ‚ΠΎΡ€Π½ΠΈ Π»Π΅ΠΊΠΎΠ²ΠΈ, кардиоваскуларни ΠΈ ΠΏΡΠΈΡ…ΠΈΡ˜Π°Ρ‚Ρ€ΠΈΡΠΊΠΈ Π»Π΅ΠΊΠΎΠ²ΠΈ. ΠŸΠΎΡ€Π°Π΄ΠΈ Π·Π³ΠΎΠ»Π΅ΠΌΡƒΠ²Π°ΡšΠ΅ Π½Π° ΠΏΠΎΠΏΡƒΠ»Π°Ρ†ΠΈΡ˜Π°Ρ‚Π° Π½Π° Π»ΠΈΡ†Π° Π½Π° ΠΏΠΎΠ»ΠΈΠΏΡ€Π°Π³ΠΌΠ°Π·ΠΈΡ˜Π° ΠΈ Π½ΠΈΠ²Π½Π°Ρ‚Π° ΠΏΠΎΡ‚Ρ€Π΅Π±Π° ΠΎΠ΄ ΡΡ‚ΠΎΠΌΠ°Ρ‚ΠΎΠ»ΠΎΡˆΠΊΠΈ Ρ‚Ρ€Π΅Ρ‚ΠΌΠ°Π½, Π½Π΅ΠΎΠΏΡ…ΠΎΠ΄Π½ΠΎ Π΅ стоматолозитС Π΄Π° Π±ΠΈΠ΄Π°Ρ‚ Π·Π°ΠΏΠΎΠ·Π½Π°Ρ‚ΠΈ со ΠΈΠ½Ρ‚Π΅Ρ€Π°ΠΊΡ†ΠΈΠΈΡ‚Π΅ со Π»Π΅ΠΊΠΎΠ²ΠΈ кај ΠΎΠ²ΠΈΠ΅ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΈ. Иако ΠΎΠ²ΠΈΠ΅ аспСкти сС ΠΏΡ€ΠΎΡƒΡ‡ΡƒΠ²Π°Π½ΠΈ Π²ΠΎ Ρ€Π°Π·Π»ΠΈΡ‡Π½ΠΈ области Π½Π° ΠΌΠ΅Π΄ΠΈΡ†ΠΈΠ½Π°Ρ‚Π°, сСпак ΠΏΠΎΡΡ‚ΠΎΡ˜Π°Ρ‚ ΠΌΠ°Π»ΠΊΡƒ студии Π·Π° Π»Π΅ΠΊΠΎΠ²ΠΈΡ‚Π΅ ΠΏΡ€Π΅ΠΏΠΈΡˆΡƒΠ²Π°Π½ΠΈ Π²ΠΎ ΡΡ‚ΠΎΠΌΠ°Ρ‚ΠΎΠ»ΠΎΠ³ΠΈΡ˜Π°Ρ‚Π° Π·Π°Π΅Π΄Π½ΠΎ со Π»Π΅ΠΊΠΎΠ²ΠΈΡ‚Π΅ Π·Π° Π΄Ρ€ΡƒΠ³ΠΈ мСдицински ΡΠΎΡΡ‚ΠΎΡ˜Π±ΠΈ кај ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΡ‚. Π—Π°Ρ‚ΠΎΠ°, ΠΎΠ²Π° ΠΏΡ€Π΅Π΄Π°Π²Π°ΡšΠ΅ ΠΈΠΌΠ° Π·Π° Ρ†Π΅Π» Π΄Π° ΠΎΠ±Ρ€Π½Π΅ Π²Π½ΠΈΠΌΠ°Π½ΠΈΠ΅ Π½Π° ΠΎΠΏΡ€Π°Π²Π΄Π°Π½Π°Ρ‚Π° загриТСност ΠΈ Π΄Π° Π³ΠΈ Π°Π½Π°Π»ΠΈΠ·ΠΈΡ€Π° ΠΏΠΎΡ‚Π΅Π½Ρ†ΠΈΡ˜Π°Π»Π½ΠΈΡ‚Π΅ ΠΈΠ½Ρ‚Π΅Ρ€Π°ΠΊΡ†ΠΈΠΈ со Π»Π΅ΠΊΠΎΠ²ΠΈ ΠΏΠΎΠΌΠ΅Ρ“Ρƒ Π²ΠΎΠΎΠ±ΠΈΡ‡Π°Π΅Π½ΠΈΡ‚Π΅ Π»Π΅ΠΊΠΎΠ²ΠΈ Π²ΠΎ ΡΡ‚ΠΎΠΌΠ°Ρ‚ΠΎΠ»ΠΎΠ³ΠΈΡ˜Π°Ρ‚Π° ΠΈ ΠΈΠ·Π±Ρ€Π°Π½ΠΈ Π»Π΅ΠΊΠΎΠ²ΠΈ ΠΊΠΎΠΈ Π΄Π΅Π»ΡƒΠ²Π°Π°Ρ‚ Π½Π° кардиоваскуларниот систСм ΠΊΠ°ΠΊΠΎ Π΅Π΄Π½Π° ΠΎΠ΄ Π³Ρ€ΡƒΠΏΠΈΡ‚Π΅ Π»Π΅ΠΊΠΎΠ²ΠΈΡ‚Π΅ ΠΊΠΎΠΈ Π½Π°Ρ˜Ρ‡Π΅ΡΡ‚ΠΎ сС администрираат истоврСмСно кај ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΈΡ‚Π΅

    Π—Π½Π°Ρ‡Π΅ΡšΠ΅ Π½Π° ΡΠ»Π΅Π΄Π΅ΡšΠ΅Ρ‚ΠΎ Π½Π° бСзбСдноста Π½Π° ΠΏΡ€ΠΈΠΌΠ΅Π½Π°Ρ‚Π° Π½Π° Π»Π΅ΠΊΠΎΠ²ΠΈΡ‚Π΅ ΠΏΠΎ Π½ΠΈΠ²Π½ΠΎΡ‚ΠΎ ΠΏΡƒΡˆΡ‚Π°ΡšΠ΅ Π²ΠΎ ΠΏΡ€ΠΎΠ΄Π°ΠΆΠ±Π°

    Get PDF
    Π’Π΅Ρ€Π°ΠΏΠΈΡ˜Π°Ρ‚Π° со Π»Π΅ΠΊΠΎΠ²ΠΈ ΠΈ ΠΏΡ€Π΅ΠΏΠΈΡˆΡƒΠ²Π°ΡšΠ΅Ρ‚ΠΎ Π»Π΅ΠΊΠΎΠ²ΠΈ, сС Π½Π°Ρ˜Ρ‡Π΅ΡΡ‚ΠΈ активности ΠΈ Π²ΠΎ ΡƒΠ»ΠΎΠ³Π° Π½Π° ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ ΠΈ Π²ΠΎ ΡƒΠ»ΠΎΠ³Π° Π½Π° ΠΎΠ½ΠΈΠ΅ ΠΊΠΎΠΈ сС Π³Ρ€ΠΈΠΆΠ°Ρ‚ Π·Π° ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΈΡ‚Π΅. НСопходно сС Π½Π°ΠΌΠ΅Ρ‚Π½ΡƒΠ²Π° ΠΏΠΎΡ‚Ρ€Π΅Π±Π°Ρ‚Π° Π΄Π° ΠΏΡ€ΠΈΠΌΠ΅Π½Π°Ρ‚Π° Π½Π° Π»Π΅ΠΊΠΎΠ²ΠΈΡ‚Π΅ Π±ΠΈΠ΄Π΅ ΠΌΠΎΠ½ΠΈΡ‚ΠΎΡ€ΠΈΡ€Π°Π½Π° со Π΅Π΄Π½Π°ΠΊΠ²ΠΎ високи стандарди ΠΊΠ°ΠΊΠΎ ΠΎΠ½ΠΈΠ΅ ΠΊΠΎΠΈ ΠΏΠΎΡΡ‚ΠΎΡ˜Π°Ρ‚ Π²ΠΎ Ρ‚Π΅ΠΊ Π½Π° Ρ€Π°Π·Π²ΠΎΡ˜ΠΎΡ‚ ΠΈ Π΅Π²Π°Π»ΡƒΠ°Ρ†ΠΈΡ˜Π°Ρ‚Π° Π½Π° иститС

    Π£ΠΏΠΎΡ‚Ρ€Π΅Π±Π°Ρ‚Π° Π½Π° цСфтриаксон Π²ΠΎ Π±ΠΎΠ»Π½ΠΈΡ‡ΠΊΠ°Ρ‚Π° ΠΈ унивСрзитСтска ΠΊΠ»ΠΈΠ½ΠΈΡ‡ΠΊΠ° слуТба Π½Π° Косово (HUCSK) Π·Π° Π²Ρ€Π΅ΠΌΠ΅ Π½Π° ΠΏΠ°Π½Π΄Π΅ΠΌΠΈΡ˜Π°Ρ‚Π° ΠšΠžΠ’Π˜Π”-19

    Get PDF
    Π“Π»ΠΎΠ±Π°Π»Π½ΠΈΡ‚Π΅ здравствСни систСми сС ΡΠΎΠΎΡ‡ΠΈΡ˜Π° со Π³ΠΎΠ»Π΅ΠΌΠΈ ΠΏΡ€Π΅Π΄ΠΈΠ·Π²ΠΈΡ†ΠΈ ΠΊΠ°ΠΊΠΎ Ρ€Π΅Π·ΡƒΠ»Ρ‚Π°Ρ‚ Π½Π° ΠΏΠ°Π½Π΄Π΅ΠΌΠΈΡ˜Π°Ρ‚Π° ΠšΠžΠ’Π˜Π”-19. ΠŸΠΎΡ‚Ρ€Π΅Π±Π°Ρ‚Π° ΠΎΠ΄ Π΅Ρ„Π΅ΠΊΡ‚ΠΈΠ²Π½ΠΈ Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ Π·Π° ΠΊΠΎΠ½Ρ‚Ρ€ΠΎΠ»Π° Π½Π° болСста ΠΈ Π½Π΅Ρ˜Π·ΠΈΠ½ΠΈΡ‚Π΅ нСсакани Π΅Ρ„Π΅ΠΊΡ‚ΠΈ сè ΡƒΡˆΡ‚Π΅ Π΅ ΠΏΡ€ΠΈΠΎΡ€ΠΈΡ‚Π΅Ρ‚. Π£ΠΏΠΎΡ‚Ρ€Π΅Π±Π°Ρ‚Π° Π½Π° цСфтриаксон, Π°Π½Ρ‚ΠΈΠ±ΠΈΠΎΡ‚ΠΈΠΊ со ΡˆΠΈΡ€ΠΎΠΊ спСктар, Π²ΠΎ Π±ΠΎΠ»Π½ΠΈΡ‡ΠΊΠΈ услови Π²ΠΎ Косово Π·Π° Π²Ρ€Π΅ΠΌΠ΅ Π½Π° ΠΏΠ°Π½Π΄Π΅ΠΌΠΈΡ˜Π°Ρ‚Π° Π½Π° ΠšΠžΠ’Π˜Π”-19 Π΅ Π³Π»Π°Π²Π½Π°Ρ‚Π° Ρ‚Π΅ΠΌΠ° Π½Π° ΠΎΠ²Π° ΠΈΡΡ‚Ρ€Π°ΠΆΡƒΠ²Π°ΡšΠ΅ ΠΊΠ°Π΄Π΅ сС Π·Π΅ΠΌΠ΅Π½ΠΈ Π²ΠΎ ΠΏΡ€Π΅Π΄Π²ΠΈΠ΄ ΠΈ ΠΌΠΎΠΆΠ½ΠΈΡ‚Π΅ прСдности ΠΈ нСдостатоци ΠΎΠ΄ Π°Π΄ΠΌΠΈΠ½ΠΈΡΡ‚Ρ€Π°Ρ†ΠΈΡ˜Π°Ρ‚Π° Π½Π° истиот. Π’ΠΎ рСтроспСктивна ΡΡ‚ΡƒΠ΄ΠΈΡ˜Π°, Π±Π΅Π° испитани ΠΏΡ€ΠΎΡ‚ΠΎΠΊΠΎΠ»ΠΈΡ‚Π΅ Π·Π° Ρ‚Ρ€Π΅Ρ‚ΠΌΠ°Π½ ΠΈ мСдицинската Π΅Π²ΠΈΠ΄Π΅Π½Ρ†ΠΈΡ˜Π° (Π²ΠΊΠ»ΡƒΡ‡ΡƒΠ²Π°Ρ˜ΡœΠΈ ја Π΄ΠΎΠ·Π°Ρ‚Π°, Π²Ρ€Π΅ΠΌΠ΅Ρ‚Ρ€Π°Π΅ΡšΠ΅Ρ‚ΠΎ Π½Π° Ρ‚Π΅Ρ€Π°ΠΏΠΈΡ˜Π°Ρ‚Π° ΠΈ исходот кај ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΡ‚) Π²ΠΎ Π±ΠΎΠ»Π½ΠΈΡ†ΠΈΡ‚Π΅. Π‘ΠΏΠΎΡ€Π΅Π΄ ΠΏΠΎΠ΄Π°Ρ‚ΠΎΡ†ΠΈΡ‚Π΅, цСфтриаксон Π²ΠΎΠΎΠ±ΠΈΡ‡Π°Π΅Π½ΠΎ сС ΠΏΡ€Π΅ΠΏΠΎΡ€Π°Ρ‡ΡƒΠ²Π°Π» Π²ΠΎ мСдицинскитС установи Π·Π° Π»Π΅ΠΊΡƒΠ²Π°ΡšΠ΅ Π½Π° ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΈ со ΠšΠžΠ’Π˜Π”-19 ΠΊΠΎΠΈ ΠΈΠΌΠ°Π»Π΅ сСкундарни бактСриски Π·Π°Π±ΠΎΠ»ΡƒΠ²Π°ΡšΠ° ΠΈΠ»ΠΈ сС смСтало Π΄Π΅ΠΊΠ° ΠΈΠΌΠ°Π°Ρ‚ истоврСмСни ΠΊΠΎ-ΠΈΠ½Ρ„Π΅ΠΊΡ†ΠΈΠΈ со Π±Π°ΠΊΡ‚Π΅Ρ€ΠΈΠΈ. ЧСсто сС ΠΊΠΎΠΌΠ±ΠΈΠ½ΠΈΡ€Π°Π» со Π΄Ρ€ΡƒΠ³ΠΈ Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ, Π²ΠΊΠ»ΡƒΡ‡ΡƒΠ²Π°Ρ˜ΡœΠΈ ΠΈΠΌΡƒΠ½ΠΎΠΌΠΎΠ΄ΡƒΠ»Π°Ρ‚ΠΎΡ€ΠΈ ΠΈΠ»ΠΈ антивирусни Π»Π΅ΠΊΠΎΠ²ΠΈ. Π’ΠΎ Π½Π΅ΠΊΠΎΠ»ΠΊΡƒ случаи, Π°Π½Ρ‚ΠΈΠ±ΠΈΠΎΡ‚ΠΈΠΊΠΎΡ‚ Π±ΠΈΠ» ΡƒΡΠΏΠ΅ΡˆΠ΅Π½ Π²ΠΎ ΠΌΠΈΠ½ΠΈΠΌΠΈΠ·ΠΈΡ€Π°ΡšΠ΅Ρ‚ΠΎ Π½Π° бактСрискитС ΠΏΡ€ΠΎΠ±Π»Π΅ΠΌΠΈ ΠΈ ΠΏΠΎΠ΄ΠΎΠ±Ρ€ΡƒΠ²Π°ΡšΠ΅ Π½Π° тСрапСвтскитС Ρ€Π΅Π·ΡƒΠ»Ρ‚Π°Ρ‚ΠΈ. Но, ΠΈΠΌΠ°Π»ΠΎ ΠΈ нСдостатоци, ΠΊΠ°ΠΊΠΎ ΡˆΡ‚ΠΎ Π΅ Π·Π³ΠΎΠ»Π΅ΠΌΡƒΠ²Π°ΡšΠ΅Ρ‚ΠΎ Π½Π° Ρ€Π΅Π·ΠΈΡΡ‚Π΅Π½Ρ†ΠΈΡ˜Π°Ρ‚Π° ΠΊΠΎΠ½ Π°Π½Ρ‚ΠΈΠ±ΠΈΠΎΡ‚ΠΈΡ†ΠΈ ΠΈ нССфСктивност Π½Π° Ρ‚Π΅Ρ€Π°ΠΏΠΈΡ˜Π°Ρ‚Π°. Π Π΅Π·ΡƒΠ»Ρ‚Π°Ρ‚ΠΈΡ‚Π΅ ΠΏΠΎΠΊΠ°ΠΆΡƒΠ²Π°Π°Ρ‚ Π΄Π΅ΠΊΠ° цСфтриаксон ΠΌΠΎΠΆΠ΅ Π΄Π° Π±ΠΈΠ΄Π΅ корисСн Π²ΠΎ Ρ‚Ρ€Π΅Ρ‚ΠΈΡ€Π°ΡšΠ΅Ρ‚ΠΎ Π½Π° ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΈ со ΠšΠžΠ’Π˜Π”-19 Π²ΠΎ Π±ΠΎΠ»Π½ΠΈΡ†ΠΈΡ‚Π΅, Π½ΠΎ само ΠΊΠΎΠ³Π° сС присутни бактСриски ΠΊΠΎ-ΠΈΠ½Ρ„Π΅ΠΊΡ†ΠΈΠΈ. Π‘Π΅ΠΏΠ°ΠΊ, Π΅Ρ„Π΅ΠΊΡ‚ΠΈΠ²Π½ΠΈΠΎΡ‚ ΠΈΠ·Π±ΠΎΡ€ Π½Π° ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΈ, ΠΎΠΏΡ‚ΠΈΠΌΠΈΠ·Π°Ρ†ΠΈΡ˜Π°Ρ‚Π° Π½Π° Π΄ΠΎΠ·Π°Ρ‚Π° ΠΈ моТноста Π·Π° Ρ€Π°Π·Π²ΠΎΡ˜ Π½Π° Ρ€Π΅Π·ΠΈΡΡ‚Π΅Π½Ρ†ΠΈΡ˜Π° ΠΊΠΎΠ½ Π°Π½Ρ‚ΠΈΠ±ΠΈΠΎΡ‚ΠΈΡ†ΠΈ Ρ‚Ρ€Π΅Π±Π° Π²Π½ΠΈΠΌΠ°Ρ‚Π΅Π»Π½ΠΎ Π΄Π° сС Ρ€Π°Π·Π³Π»Π΅Π΄Π°. Π—Π° Π΄Π° сС ΠΈΠ·Π±Π΅Π³Π½Π΅ Π·Π»ΠΎΡƒΠΏΠΎΡ‚Ρ€Π΅Π±Π°Ρ‚Π° Π½Π° Π°Π½Ρ‚ΠΈΠ±ΠΈΠΎΡ‚ΠΈΡ†ΠΈ ΠΈ појава Π½Π° Ρ€Π΅Π·ΠΈΡΡ‚Π΅Π½Ρ†ΠΈΡ˜Π°, ΡΠ΅Π»Π΅ΠΊΡ†ΠΈΡ˜Π°Ρ‚Π° Π½Π° ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΈΡ‚Π΅ спорСд ΠΏΡ€Π΅ΠΏΠΎΡ€Π°ΠΊΠΈΡ‚Π΅ ΠΌΠΎΡ€Π° Π΄Π° Π±ΠΈΠ΄Π΅ ΠΏΡ€ΠΈΠΎΡ€ΠΈΡ‚Π΅Ρ‚

    Π’Π΅Ρ€Π°ΠΏΠΈΡ˜Π° со CAR (Chimeric Antigen Receptor) Π’ - ΠΊΠ»Π΅Ρ‚ΠΊΠΈ ΠΊΠ°ΠΊΠΎ Π½ΠΎΠ²Π° Π°Π½Ρ‚ΠΈΠΊΠ°Π½Ρ†Π΅Ρ€Π½Π° Ρ‚Π΅Ρ€Π°ΠΏΠΈΡ˜Π°

    Get PDF
    ΠšΠ°Π½Ρ†Π΅Ρ€ΠΎΡ‚ Π΅ Π΅Π΄Π½Π° ΠΎΠ΄ Π²ΠΎΠ΄Π΅Ρ‡ΠΊΠΈΡ‚Π΅ ΠΏΡ€ΠΈΡ‡ΠΈΠ½ΠΈ Π·Π° смртност Π²ΠΎ свСтот ΠΏΠΎΡ€Π°Π΄ΠΈ Π½Π΅Π³ΠΎΠ²Π°Ρ‚Π° висока Ρ„Ρ€Π΅ΠΊΠ²Π΅Π½Ρ†ΠΈΡ˜Π° Π½Π° Ρ˜Π°Π²ΡƒΠ²Π°ΡšΠ΅ ΠΈ нСдостатокот Π½Π° Π΅Ρ„Π΅ΠΊΡ‚ΠΈΠ²Π½ΠΈ ΠΈ Сфикасни Π»Π΅ΠΊΠΎΠ²ΠΈ Π·Π° Ρ‚Ρ€Π΅Ρ‚ΠΌΠ°Π½ Π½Π° истиот. ΠžΡ‚Ρ‚ΡƒΠΊΠ° ΠΏΡ€ΠΎΠΈΠ·Π»Π΅Π³ΡƒΠ²Π° ΠΏΠΎΡ‚Ρ€Π΅Π±Π°Ρ‚Π° Π·Π° ΠΎΡ‚ΠΊΡ€ΠΈΠ²Π°ΡšΠ΅ Π½Π° Π½ΠΎΠ²ΠΈ пристапи Π·Π° Π»Π΅ΠΊΡƒΠ²Π°ΡšΠ΅ ΠΈ ΠΏΡ€Π΅Π²Π΅Π½Ρ†ΠΈΡ˜Π°. Π₯ΠΈΡ€ΡƒΡ€ΡˆΠΊΠ°Ρ‚Π° ΠΈΠ½Ρ‚Π΅Ρ€Π²Π΅Π½Ρ†ΠΈΡ˜Π°, Ρ…Π΅ΠΌΠΎΡ‚Π΅Ρ€Π°ΠΏΠΈΡ˜Π°Ρ‚Π° ΠΈ Ρ€Π°Π΄ΠΈΠΎΡ‚Π΅Ρ€Π°ΠΏΠΈΡ˜Π°Ρ‚Π° сС Ρ‚Ρ€Π°Π΄ΠΈΡ†ΠΈΠΎΠ½Π°Π»Π½ΠΈΡ‚Π΅ Ρ‚Ρ€Π΅Ρ‚ΠΌΠ°Π½ΠΈ Π·Π° ΠΊΠ°Π½Ρ†Π΅Ρ€. НапрСдокот Π½Π° ΠΈΠΌΡƒΠ½ΠΎΠ»ΠΎΠ³ΠΈΡ˜Π°Ρ‚Π° ΠΊΠ°ΠΊΠΎ Π½Π°ΡƒΠΊΠ° Π΄ΠΎΠ²Π΅Π» Π΄ΠΎ ΠΏΠΎΠ³ΠΎΠ»Π΅ΠΌΠΎ Ρ€Π°Π·Π±ΠΈΡ€Π°ΡšΠ΅ Π½Π° Π½Π°Ρ‡ΠΈΠ½ΠΎΡ‚ Π΄Π° сС искористи сопствСниот ΠΈΠΌΡƒΠ½ΠΎΠ»ΠΎΡˆΠΊΠΈ систСм Π·Π° Ρ‚Ρ€Π΅Ρ‚ΠΌΠ°Π½ Π½Π° ΠΊΠ°Π½Ρ†Π΅Ρ€ ΠΈ Π΄Π° сС Ρ€Π°Π·Π²ΠΈΡ˜Π°Ρ‚ Ρ€Π°Π·Π»ΠΈΡ‡Π½ΠΈ ΠΎΠ±Π»ΠΈΡ†ΠΈ Π½Π° ΠΈΠΌΡƒΠ½ΠΎΡ‚Π΅Ρ€Π°ΠΏΠΈΡ˜Π° Π½Π° ΠΊΠ°Π½Ρ†Π΅Ρ€. Π’Π΅Ρ€Π°ΠΏΠΈΡ˜Π°Ρ‚Π° со CAR Π’-ΠΊΠ»Π΅Ρ‚ΠΊΠΈ сС Π½Π°Ρ€Π΅ΠΊΡƒΠ²Π° β€žΠΈΠΌΡƒΠ½ΠΎΡ‚Π΅Ρ€Π°ΠΏΠΈΡ˜Π°β€œ бидСјќи Π³ΠΈ користи сопствСнитС Π’-ΠΊΠ»Π΅Ρ‚ΠΊΠΈ Π½Π° ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΡ‚ Π·Π° Π΄Π° Π³ΠΈ ΠΏΡ€Π΅ΠΏΠΎΠ·Π½Π°Π΅ ΠΈ Π½Π°ΠΏΠ°Π΄Π½Π΅ ΠΊΠ°Π½Ρ†Π΅Ρ€Π½ΠΈΡ‚Π΅ ΠΊΠ»Π΅Ρ‚ΠΊΠΈ. Ѐункционалноста, спСцифичноста ΠΈ Сфикасноста Π½Π° CAR T-ΠΊΠ»Π΅Ρ‚ΠΊΠΈΡ‚Π΅ ΠΏΠΎΡΡ‚ΠΎΡ˜Π°Π½ΠΎ сС ΠΏΠΎΠ΄ΠΎΠ±Ρ€ΡƒΠ²Π°Π°Ρ‚. Π’ΠΎ ΠΊΠΎΠΌΠ±ΠΈΠ½Π°Ρ†ΠΈΡ˜Π° со Π½Π°ΠΏΡ€Π΅Π΄ΠΎΠΊΠΎΡ‚ Π²ΠΎ ΠΊΠ»Π΅Ρ‚ΠΎΡ‡Π½ΠΎΡ‚ΠΎ инТСнСрство ΠΈ гСнското ΠΏΡ€Π΅ΡƒΡ€Π΅Π΄ΡƒΠ²Π°ΡšΠ΅, CAR T-ΠΊΠ»Π΅Ρ‚ΠΊΠΈΡ‚Π΅ сè ΡƒΡˆΡ‚Π΅ ΠΈΠΌΠ°Π°Ρ‚ нСисполнСт ΠΏΠΎΡ‚Π΅Π½Ρ†ΠΈΡ˜Π°Π» Π²ΠΎ Ρ‚Ρ€Π΅Ρ‚ΠΌΠ°Π½ΠΎΡ‚ Π½Π° ΠΊΠ°Π½Ρ†Π΅Ρ€. ΠŸΠΎΠ·ΠΈΡ‚ΠΈΠ²Π½ΠΈΠΎΡ‚ Ρ€Π°Π·Π²ΠΎΡ˜ ΠΏΠΎΠΊΠ°ΠΆΡƒΠ²Π° Π΄Π΅ΠΊΠ° CAR T-Ρ‚Π΅Ρ€Π°ΠΏΠΈΡ˜Π°Ρ‚Π° нСсомнСно ΠΎΠ·Π½Π°Ρ‡ΡƒΠ²Π° Π½ΠΎΠ²Π° Π΅Ρ€Π° Π²ΠΎ Ρ‚Π΅Ρ€Π°ΠΏΠΈΡ˜Π°Ρ‚Π° Π·Π° ΠΊΠ°Π½Ρ†Π΅Ρ€ ΠΈ ΠΏΠΎΡ‡Π΅Ρ‚ΠΎΠΊ Π½Π° пСрсонализирана ΠΊΠ»Π΅Ρ‚ΠΎΡ‡Π½Π° Ρ‚Π΅Ρ€Π°ΠΏΠΈΡ˜Π° со насочСно Π΄Π΅Ρ˜ΡΡ‚Π²ΠΎ

    ΠŸΡ€ΠΈΠΌΠ΅Π½Π° Π½Π° NRF2 ΠΈΠ½Ρ…ΠΈΠ±ΠΈΡ‚ΠΎΡ€ΠΈ ΠΊΠ°ΠΊΠΎ ΠΏΠΎΡ‚Π΅Π½Ρ†ΠΈΡ˜Π°Π»Π½ΠΈ антинСопластични Π»Π΅ΠΊΠΎΠ²ΠΈ

    Get PDF
    По кардиоваскуларнитС Π·Π°Π±ΠΎΠ»ΡƒΠ²Π°ΡšΠ°, ΠΊΠ°Π½Ρ†Π΅Ρ€ΠΎΡ‚ Π΅ Π²Ρ‚ΠΎΡ€Π°Ρ‚Π° ΠΏΡ€ΠΈΡ‡ΠΈΠ½Π° Π·Π° смртност Π²ΠΎ свСтот, Π° сС ΠΎΡ‡Π΅ΠΊΡƒΠ²Π° истиот Π΄Π° сС ΠΏΠΎΠ·ΠΈΡ†ΠΈΠΎΠ½ΠΈΡ€Π° ΠΈ Π½Π° ΠΏΡ€Π²ΠΎ мСсто Π²ΠΎ ΠΈΠ΄Π½ΠΈΠ½Π°. Оваа Ρ‚Π΅Π½Π΄Π΅Π½Ρ†ΠΈΡ˜Π° Π΅ ΠΏΠΎΠ²Ρ€Π·Π°Π½Π° со сé ΠΏΠΎΠ³ΠΎΠ»Π΅ΠΌΠΈΠΎΡ‚ Π±Ρ€ΠΎΡ˜ Π½Π° Π½ΠΎΠ²ΠΎΠ΄ΠΈΡ˜Π°Π³Π½ΠΎΡΡ‚ΠΈΡ†ΠΈΡ€Π°Π½ΠΈ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΈ ΠΊΠΎΠΌΠ±ΠΈΠ½ΠΈΡ€Π°Π½ΠΎ со нСуспСхот Π½Π° Ρ‚Π΅Ρ€Π°ΠΏΠΈΡ˜Π°Ρ‚Π° ΠΊΠ°ΠΊΠΎ Ρ€Π΅Π·ΡƒΠ»Ρ‚Π°Ρ‚ Π½Π° рСзистСнтноста Π½Π° ΠΊΠ°Π½Ρ†Π΅Ρ€Π½ΠΈΡ‚Π΅ ΠΊΠ»Π΅Ρ‚ΠΊΠΈ Π½Π° Ρ‚Ρ€Π΅Ρ‚ΠΌΠ°Π½ΠΎΡ‚ ΠΈ ΠΏΠΎΠΊΡ€Π°Ρ˜ Π½Π°ΠΏΡ€Π΅Π΄ΠΎΠΊΠΎΡ‚ Π½Π° Ρ…Π΅ΠΌΠΎΡ‚Π΅Ρ€Π°ΠΏΠΈΡ˜Π°Ρ‚Π° ΠΈ Ρ€Π°Π΄ΠΈΠΎΡ‚Π΅Ρ€Π°ΠΏΠΈΡ˜Π°Ρ‚Π° ΠΊΠ°ΠΊΠΎ Π½Π°Ρ˜ΡˆΠΈΡ€ΠΎΠΊΠΎ користСни Π½Π°Ρ‡ΠΈΠ½ΠΈ Π·Π° Π»Π΅ΠΊΡƒΠ²Π°ΡšΠ΅ Π½Π° ΠΊΠ°Π½Ρ†Π΅Ρ€. Π—Π°Ρ€Π°Π΄ΠΈ Ρ‚ΠΎΠ° постои ΠΈΡ‚Π½Π° ΠΏΠΎΡ‚Ρ€Π΅Π±Π° Π·Π° ΠΈΠ·Π½Π°ΠΎΡ“Π°ΡšΠ΅ Π½Π° Π΅Ρ„Π΅ΠΊΡ‚ΠΈΠ²Π½ΠΈ ΠΈ Сфикасни Π»Π΅ΠΊΠΎΠ²ΠΈ Π·Π° болСста која Π½Π΅ Π±ΠΈΡ€Π° возраст. Π‘ΠΏΠΎΡ€Π΅Π΄ нСодамнСшни студии, кај ΠΌΠ½ΠΎΠ³Ρƒ Ρ‚ΡƒΠΌΠΎΡ€ΠΈ постои пСрзистСнтно Π°ΠΊΡ‚ΠΈΠ²Π΅Π½ Nuclear factor erythroid 2-related factor 2 (NRF2), Ρ†ΠΈΡ‚ΠΎΠΏΡ€ΠΎΡ‚Π΅ΠΊΡ‚ΠΈΠ²Π΅Π½ транскрипциски Ρ„Π°ΠΊΡ‚ΠΎΡ€ кој ΠΊΠ°ΠΊΠΎ Π·Π΄Ρ€Π°Π²ΠΈΡ‚Π΅, Π³ΠΈ Π·Π°ΡˆΡ‚ΠΈΡ‚ΡƒΠ²Π° ΠΈ туморскитС ΠΊΠ»Π΅Ρ‚ΠΊΠΈ, ΠΏΡ€ΠΈΡ‚ΠΎΠ° ΠΎΠ²ΠΎΠ·ΠΌΠΎΠΆΡƒΠ²Π°Ρ˜ΡœΠΈ ΠΈΠΌ Ρ€Π΅Π·ΠΈΡΡ‚Π΅Π½Ρ†ΠΈΡ˜Π° ΠΊΠΎΠ½ Ρ‚Π΅Ρ€Π°ΠΏΠΈΡ˜Π°Ρ‚Π° ΠΈ Ρ‚ΠΎΠ° ΠΏΡ€Π΅ΠΊΡƒ ΠΈΠ½Π΄ΡƒΠΊΡ†ΠΈΡ˜Π° Π½Π° Ρ‚Ρ€Π°Π½ΡΠΊΡ€ΠΈΠΏΡ†ΠΈΡ˜Π°Ρ‚Π° Π½Π° Ρ†ΠΈΡ‚ΠΎΠΏΡ€ΠΎΡ‚Π΅ΠΊΡ‚ΠΈΠ²Π½ΠΈΡ‚Π΅ Π³Π΅Π½ΠΈ ΠΈ Π·Π°Ρ˜Π°ΠΊΠ½ΡƒΠ²Π°ΡšΠ΅Ρ‚ΠΎ Π½Π° ΠΎΠ΄Π±Ρ€Π°Π½Π±Π΅Π½ΠΈΠΎΡ‚ систСм Π²ΠΎ ΠΊΠ»Π΅Ρ‚ΠΊΠ°Ρ‚Π°. Π‘ΠΏΠΎΡ€Π΅Π΄ Ρ‚ΠΎΠ°, NRF2 сигналната ΠΏΠ°Ρ‚Π΅ΠΊΠ° ΠΊΠ°ΠΊΠΎ Π²Π°ΠΆΠ΅Π½ ΠΊΠ»Π΅Ρ‚ΠΎΡ‡Π΅Π½ ΠΎΠ΄Π±Ρ€Π°Π½Π±Π΅Π½ ΠΌΠ΅Ρ…Π°Π½ΠΈΠ·Π°ΠΌ, ΠΌΠΎΠΆΠ΅ Π΄Π° прСтставува Ρ†Π΅Π»Π½ΠΎ мСсто Π·Π° Ρ„Π°Ρ€ΠΌΠ°ΠΊΠΎΠ»ΠΎΡˆΠΊΠΈ Ρ‚Ρ€Π΅Ρ‚ΠΌΠ°Π½ Π½Π° ΠΊΠ°Π½Ρ†Π΅Ρ€. Π•Π΄Π΅Π½ ΠΎΠ΄ пристапитС Π΅ ΠΏΡ€ΠΈΠΌΠ΅Π½Π°Ρ‚Π° Π½Π° NRF2 ΠΈΠ½Ρ…ΠΈΠ±ΠΈΡ‚ΠΎΡ€ΠΈ со ΠΊΠΎΠΈ сС Π±Π»ΠΎΠΊΠΈΡ€Π° Π½Π΅Ρ˜Π·ΠΈΠ½Π°Ρ‚Π° активност, Π° со Ρ‚ΠΎΠ° ΠΈ ΠΎΠ΄Π±Ρ€Π°Π½Π±Π΅Π½ΠΈΠΎΡ‚ систСм кај туморскитС ΠΊΠ»Π΅Ρ‚ΠΊΠΈ рСзистСнтни Π½Π° Ρ‚Ρ€Π΅Ρ‚ΠΌΠ°Π½ со послСдоватСлна ΠΊΠ»Π΅Ρ‚ΠΎΡ‡Π½Π° смрт. Π‘Π΅ Ρ€Π°Π±ΠΎΡ‚ΠΈ Π·Π° ΠΈΠ·Π²ΠΎΠ½Ρ€Π΅Π΄Π½Π° ΡΡ‚Ρ€Π°Ρ‚Π΅Π³ΠΈΡ˜Π° Π·Π° Π»Π΅ΠΊΡƒΠ²Π°ΡšΠ΅ Π½Π° Ρ‚ΡƒΠΌΠΎΡ€ΠΈ ΠΊΠΎΠΈ ΠΏΠΎΡ€Π°Π΄ΠΈ Ρ…ΠΈΠΏΠ΅Ρ€Π°ΠΊΡ‚ΠΈΠ²Π°Ρ†ΠΈΡ˜Π° Π½a Nrf2 сигналната ΠΏΠ°Ρ‚Π΅ΠΊΠ° ΠΈΠΌΠ°Π°Ρ‚ агрСсивна ΠΏΡ€ΠΎΠ³Ρ€Π΅ΡΠΈΡ˜Π° ΠΈ сС ΠΏΠΎΠ²Ρ€Π·Π°Π½ΠΈ со лоша ΠΏΡ€ΠΎΠ³Π½ΠΎΠ·Π°. Π’ΠΎ ΠΈΠ΄Π½ΠΈΠ½Π° ΠΏΠΎΡ‚Ρ€Π΅Π±Π΅Π½ Π΅ ΠΊΠΎΠ½Ρ‚ΠΈΠ½ΡƒΠΈΡ€Π°Π½ Ρ€Π°Π·Π²ΠΎΡ˜ Π½Π° моќни, спСцифични ΠΈ Сфикасни Nrf2 ΠΈΠ½Ρ…ΠΈΠ±ΠΈΡ‚ΠΎΡ€ΠΈ ΠΊΠΎΠΈ Π±ΠΈ прСтставувалС Π½ΠΎΠ²Π° антинСопластична Ρ‚Π΅Ρ€Π°ΠΏΠΈΡ˜Π°

    Approach to detect possible genotoxic effects of metals in plants

    Get PDF
    During the intensive research in past decades, the scientific community and regulatory agencies also, focused their interest on measuring contaminant levels in tissues and environmental samples and on understanding the mechanisms of toxicity of different and pervasive contaminants. Among them, metals were always in focus because of possible detrimental and long lasting effects on living organisms. The current study was designed to assess the effects of long term, high metal exposition (cadmium, lead, copper, nickel and zinc) on DNA damage

    Dietary Pattern and Health Outcomes – Mediterranean Diet Approach in Kosovo

    Get PDF
    Definitions of the Mediterranean diet (MD) are divergent in different sources, and some concepts are overlapping with other dietary patterns with known health benefit. The traditional MD mainly reflect plant-based dietary pattern considering high consumption of vegetables, fruits and nuts, legumes, and cereals (not processed), low consumption of meat and meat products, and dairy products. The Mediterranean diet has been linked to a number of health benefits, including reduced mortality risk and lower incidence of cardiovascular disease, and in the last years entered the medical literature rapidly. Higher adherence to the Mediterranean diet is linked to a lower risk of obesity, a variety of noncommunicable diseases (such as diabetes, cardiovascular disease, cancer, and metabolic syndrome), as well as mental problems, according to the published academic researches. But, even within the Euro-Mediterranean region, attention to the Mediterranean diet varies from one nation to the next. Kosovo, as part of the Western Balkans (which include Albania, Bosnia and Herzegovina, Croatia, North Macedonia, Montenegro, and Serbia), is continental, landlocked country, where dietary habits (ex., adherence to MD) and connection with lifestyle and health status have not been studied yet, there are lack of data, or is generally considered only in multi-country surveys. Does, the present study shows our intention to evaluate adherence to MD and its impact on lifestyle, physical activity and health outcome among inhabitants from different areas of Kosovo, with main goal to assess how sustainability of the MD is linked in different circumstances with environment, economy, sociocultural, and nutrition-health issues. The preliminary data from the ongoing study, shows low to middle score of adherence to MD, and that more hard-working strategies are needed to make MD approach more familiar to the people while address health outcomes

    Plant bioactive compounds affecting biomarkers and final outcome of COVID-19

    Get PDF
    Herbal medicinal products are known for their widespread use toward various viral infections and ease of disease symptoms. Therefore, the sudden appearance of the Severe Acute Respiratory Syndrome-related Coronavirus 2 (SARS-CoV-2) and COVID-19 disease was no exception. Bioactive compounds from natural plant origin could act on several disease levels: through essential immunological pathways, affecting COVID-19 biomarkers, or by halting or modulating SARS-CoV-2. In this paper, we review the recently published data regarding the use of plant bioactive compounds in the prevention/treatment of COVID-19. The mode of actions responsible for these effects is discussed, including the inhibition of attachment, penetration and release of the virus, actions affecting RNA, protein synthesis and viral proteases, as well as other mechanisms. The reviewed information suggests that plant bioactive compounds can be used alone or in combinations, but upcoming, extensive and global studies on several factors involved are needed to recognize indicative characteristics and various patterns of bioactive compounds use, related with an array of biomarkers connected to different elements of inflammatory and immune-related processes of COVID-19 disease

    Π•Π²Π°Π»ΡƒΠ°Ρ†ΠΈΡ˜Π° Π½Π° ΠΏΠΎΠ·Π½Π°Π²Π°ΡšΠ°Ρ‚Π° Π·Π° мСдитСранската Π΄ΠΈΠ΅Ρ‚Π° кај студСнтитС ΠΏΠΎ Ρ„Π°Ρ€ΠΌΠ°Ρ†ΠΈΡ˜Π° Π²ΠΎ Косово

    Get PDF
    ΠœΠ΅Π΄ΠΈΡ‚Π΅Ρ€Π°Π½ΡΠΊΠ°Ρ‚Π° Π΄ΠΈΠ΅Ρ‚Π° (ΠœΠ”) дСнСс сС смСта ΠΊΠ°ΠΊΠΎ Π³Π»Π°Π²Π΅Π½ ΠΏΡ€ΠΈΠΌΠ΅Ρ€ Π·Π° ΠΎΠ΄Ρ€ΠΆΠ»ΠΈΠ²ΠΈ Π΄ΠΈΠ΅Ρ‚ΠΈ. ΠœΠ” Π΅ ΠΏΠΎΠ²Ρ€Π·Π°Π½Π° со Π³ΠΎΠ»Π΅ΠΌ Π±Ρ€ΠΎΡ˜ здравствСни ΠΏΡ€ΠΈΠ΄ΠΎΠ±ΠΈΠ²ΠΊΠΈ, Π²ΠΊΠ»ΡƒΡ‡ΡƒΠ²Π°Ρ˜ΡœΠΈ Π½Π°ΠΌΠ°Π»Π΅Π½ Ρ€ΠΈΠ·ΠΈΠΊ ΠΎΠ΄ смртност ΠΈ ΠΏΠΎΠΌΠ°Π»Π° ΠΈΠ½Ρ†ΠΈΠ΄Π΅Π½Ρ†Π° Π½Π° кардиоваскуларни, ΠΌΠ΅Ρ‚Π°Π±ΠΎΠ»ΠΈΡ‡ΠΊΠΈ болСсти ΠΈ Π΄Ρ€ΡƒΠ³ΠΈ. Π‘ΠΏΠΎΡ€Π΅Π΄ ΠΎΠ±Ρ˜Π°Π²Π΅Π½ΠΈΡ‚Π΅ акадСмски ΠΈΡΡ‚Ρ€Π°ΠΆΡƒΠ²Π°ΡšΠ°, повисокото ΠΏΡ€ΠΈΠ΄Ρ€ΠΆΡƒΠ²Π°ΡšΠ΅ ΠΊΠΎΠ½ ΠœΠ” Π΅ ΠΏΠΎΠ²Ρ€Π·Π°Π½ΠΎ со ΠΏΠΎΠΌΠ°Π» Ρ€ΠΈΠ·ΠΈΠΊ ΠΎΠ΄ ΠΌΠ΅Ρ‚Π°Π±ΠΎΠ»ΠΈΡ‡ΠΊΠΈ синдром, ΠΊΠ°ΠΊΠΎ ΠΈ ΠΌΠ΅Π½Ρ‚Π°Π»Π½ΠΈ ΠΏΡ€ΠΎΠ±Π»Π΅ΠΌΠΈ. Оваа ΡΡ‚ΡƒΠ΄ΠΈΡ˜Π° сС фокусира Π½Π° ΠΈΠ·Π²Π»Π΅ΠΊΡƒΠ²Π°ΡšΠ΅ Π·Π°ΠΊΠ»ΡƒΡ‡ΠΎΡ†ΠΈ Π·Π° ΠΌΠΎΠΌΠ΅Π½Ρ‚Π°Π»Π½Π°Ρ‚Π° ΡΠΎΡΡ‚ΠΎΡ˜Π±Π° Π½Π° ΠΏΠΎΠ·Π½Π°Π²Π°ΡšΠ°Ρ‚Π° Π·Π° ΠœΠ” кај студСнтската ΠΏΠΎΠΏΡƒΠ»Π°Ρ†ΠΈΡ˜Π° Π²ΠΎ Косово, Π° ΠΊΡ€Π°Ρ˜Π½Π°Ρ‚Π° Ρ†Π΅Π» Π½Π° ΠΎΠ²Π°Π° ΡΡ‚ΡƒΠ΄ΠΈΡ˜Π° бСшС Π΄Π° Π³ΠΈ Π·Π³ΠΎΠ»Π΅ΠΌΠΈ ΠΈΠ½Ρ„ΠΎΡ€ΠΌΠ°Ρ†ΠΈΠΈΡ‚Π΅ Π·Π° ΠΏΡ€ΠΈΠ΄ΠΎΠ±ΠΈΠ²ΠΊΠΈΡ‚Π΅ ΠΎΠ΄ ΠΏΡ€ΠΈΠ΄Ρ€ΠΆΡƒΠ²Π°ΡšΠ΅Ρ‚ΠΎ ΠΊΠΎΠ½ истата Π²ΠΎ Π½Π°ΠΌΠ°Π»ΡƒΠ²Π°ΡšΠ΅Ρ‚ΠΎ Π½Π° Π½Π΅ΠΊΠΎΠΈ Ρ…Ρ€ΠΎΠ½ΠΈΡ‡Π½ΠΈ Π·Π°Π±ΠΎΠ»ΡƒΠ²Π°ΡšΠ°. Π“Π»Π°Π²Π΅Π½ инструмСнт Π½Π° ΡΡ‚ΡƒΠ΄ΠΈΡ˜Π°Ρ‚Π° бСшС онлајн ΠΏΡ€Π°ΡˆΠ°Π»Π½ΠΈΠΊΠΎΡ‚, дистрибуиран ΠΈ ΠΏΠΎΠΏΠΎΠ»Π½Π΅Ρ‚ ΠΎΠ΄ учСсницитС Π²ΠΎ мај 2023 Π³ΠΎΠ΄ΠΈΠ½Π°. Π”ΠΎΠ±ΠΈΠ΅Π½ΠΈΡ‚Π΅ Ρ€Π΅Π·ΡƒΠ»Ρ‚Π°Ρ‚ΠΈ ΠΏΠΎΠΊΠ°ΠΆΡƒΠ²Π°Π°Ρ‚ Π΄Π΅ΠΊΠ° 56% ΠΎΠ΄ учСсницитС Π±ΠΈΠ»Π΅ ΠΈΠ½Ρ„ΠΎΡ€ΠΌΠΈΡ€Π°Π½ΠΈ Π·Π° ΠœΠ” ΠΏΡ€Π΅ΠΊΡƒ ΡΠΎΡ†ΠΈΡ˜Π°Π»Π½ΠΈΡ‚Π΅ ΠΌΡ€Π΅ΠΆΠΈ, Π° 17% Π·Π° ΠΏΡ€Π²ΠΏΠ°Ρ‚ Π΄ΠΎΠ·Π½Π°Π»Π΅ Π½Π° Ρ„Π°ΠΊΡƒΠ»Ρ‚Π΅Ρ‚. 47% ΠΎΠ΄ студСнтитС смСтаат Π΄Π΅ΠΊΠ° MΠ” ΠΌΠΎΠΆΠ΅ Π΄Π° Π³ΠΎ ΠΏΡ€ΠΎΠΌΠ΅Π½ΠΈ Π½Π°Ρ‡ΠΈΠ½ΠΎΡ‚ Π½Π° ΠΆΠΈΠ²ΠΎΡ‚. ΠŸΠΎΠ²Π΅ΡœΠ΅Ρ‚ΠΎ ΠΎΠ΄ учСсницитС, 78%, сС согласија Π΄Π΅ΠΊΠ° ΠΏΡ€ΠΈΠ΄Ρ€ΠΆΡƒΠ²Π°ΡšΠ΅Ρ‚ΠΎ ΠΊΠΎΠ½ ΠœΠ”, Π°ΠΊΠΎ Π΅ ΠΎΠ³Ρ€Π°Π½ΠΈΡ‡Π΅Π½ внСсот Π½Π° ΠΊΠ°Π»ΠΎΡ€ΠΈΠΈ, ΠΌΠΎΠΆΠ΅ Π΄Π° ΠΏΠΎΠΌΠΎΠ³Π½Π΅ Π²ΠΎ Π³ΡƒΠ±Π΅ΡšΠ΅Ρ‚ΠΎ ΠΈ ΠΎΠ΄Ρ€ΠΆΡƒΠ²Π°ΡšΠ΅Ρ‚ΠΎ Π½Π° Ρ‚Π΅ΠΆΠΈΠ½Π°Ρ‚Π°. Π‘Ρ‚ΡƒΠ΄Π΅Π½Ρ‚ΠΈΡ‚Π΅ ΠΏΠΎ Ρ„Π°Ρ€ΠΌΠ°Ρ†ΠΈΡ˜Π° Π³Π΅Π½Π΅Ρ€Π°Π»Π½ΠΎ сС заинтСрСсирани Π·Π° ΠœΠ” бидСјќи мислат Π΄Π΅ΠΊΠ° ΠœΠ” ΠΈΠ³Ρ€Π° Π²Π°ΠΆΠ½Π° ΡƒΠ»ΠΎΠ³Π° Π²ΠΎ ΠΆΠΈΠ²ΠΎΡ‚Π½ΠΈΠΎΡ‚ стил ΠΈ Π΅ Π΄ΠΎΠ±Π°Ρ€ ΠΈΠ·Π±ΠΎΡ€ Π·Π° Π·Π΄Ρ€Π°Π²Ρ˜Π΅Ρ‚ΠΎ Π½Π° Ρ‚Π΅Π»ΠΎΡ‚ΠΎ ΠΈ ΡƒΠΌΠΎΡ‚. Π Π΅Π·ΡƒΠ»Ρ‚Π°Ρ‚ΠΈΡ‚Π΅ ΠΎΠ΄ спровСдСното ΠΈΡΡ‚Ρ€Π°ΠΆΡƒΠ²Π°ΡšΠ΅ ΠΏΠΎΠΊΠ°ΠΆΠ°Π° Π΄Π΅ΠΊΠ° информираноста ΠΈ ΠΏΠΎΠ·Π½Π°Π²Π°ΡšΠ°Ρ‚Π° Π·Π° ΠœΠ” кај студСнтската ΠΏΠΎΠΏΡƒΠ»Π°Ρ†ΠΈΡ˜Π° сС ниски Π΄ΠΎ ΡƒΠΌΠ΅Ρ€Π΅Π½ΠΈ ΠΈ ΠΌΠΎΡ€Π° Π΄Π° сС Π·Π³ΠΎΠ»Π΅ΠΌΠ°Ρ‚ Π½Π΅ само кај студСнтитС, Ρ‚ΡƒΠΊΡƒ ΠΈ Π²ΠΎΠΎΠΏΡˆΡ‚ΠΎ. ΠŸΠΎΡ‚Ρ€Π΅Π±Π½ΠΈ сС Π΄ΠΎΠΏΠΎΠ»Π½ΠΈΡ‚Π΅Π»Π½ΠΈ стратСгии ΠΊΠΎΠΈ Ρ‚Ρ€Π΅Π±Π° Π΄Π° сС спровСдат Π·Π° Π΄Π° сС Π½Π°ΠΏΡ€Π°Π²ΠΈ MΠ” ΠΏΠΎΠΏΠΎΠ·Π½Π°Ρ‚Π°, поблиска ΠΈ Π΄Π° сС Π°ΠΊΡ†Π΅Π½Ρ‚ΠΈΡ€Π°Π°Ρ‚ здравствСнитС ΠΏΡ€ΠΈΠ΄ΠΎΠ±ΠΈΠ²ΠΊΠΈ
    • …
    corecore